Max Diehn

Max Diehn, a Professor of Radiation Oncology at Stanford and an expert in lung cancer, delves into the fascinating world of liquid biopsies. He explains how these non-invasive blood tests can detect circulating tumor DNA, revolutionizing cancer detection. Diehn discusses the balance of sensitivity and specificity in cancer screening and explores the potential of cell-free DNA as biomarkers. He envisions a future where liquid biopsies can predict patient outcomes and improve early cancer detection, ultimately transforming treatment decisions.